![Carlos Morel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carlos Morel
Direktor/Vorstandsmitglied bei Foundation for Innovative New Diagnostics
Aktive Positionen von Carlos Morel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Foundation for Innovative New Diagnostics
![]() Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Carlos Morel
Ehemalige bekannte Positionen von Carlos Morel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Global Alliance for TB Drug Development
![]() Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Vorsitzender | - | - |
Statistik
International
Vereinigte Staaten | 2 |
Schweiz | 2 |
Operativ
Chairman | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Global Alliance for TB Drug Development
![]() Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Foundation for Innovative New Diagnostics
![]() Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Health Services |
- Börse
- Insiders
- Carlos Morel
- Erfahrung